ArticlePloS one2026
Nontargeted metabolomics analysis of potential biomarkers for patients with chronic ischemic stroke in extremely cold rural regions: An exploratory case-control study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveChronic ischemic stroke (CIS) is a serious cardiovascular event, closely related to genetic and environmental factors in its occurrence and development. This study aims to reveal the potential impact of extreme cold environments on patients with CIS by comparing the metabolic characteristics of different populations, and to explore potential biomarkers and metabolic differences between Daur and Han CIS patients.
methodsA total of 32 patients with CIS and 32 matched by age, sex and race healthy controls were included in this study. Their demographic data were collected and clinical indicators were measured. The potentially differential expressed metabolites (DEMs) associated with CIS were identified using liquid chromatography-mass spectrometry (LC-MS/MS). Statistical analysis was performed using SPSS 22.0 and MetaboAnalyst 6.0.
results1. There were statistically significant differences in urea nitrogen (P = 0.006), history of hypertension (P = 0.006), and history of diabetes (P = 0.046) between the patients with CIS and healthy controls. The association between a history of hypertension and CIS had an odds ratio of 4.023 (95% confidence interval 1.294-12.513). 2. Nontargeted metabolomics analysis identified 29 potential DEMs associated with CIS, which were further analyzed. A receiver operating characteristic (ROC) curve demonstrated the moderate performance (AUC = 0.750, accuracy rate = 66.5%) of these potential DEMs in identifying patients with CIS. The galactose metabolic pathway, as well as cysteine and methionine metabolism, were significantly different between the groups (P = 0.006 and P = 0.009, respectively). 3. Metabolomic analysis comparing Daur and Han patients with CIS identified 37 potential DEMs. A ROC curve for these potential DEMs was constructed (AUC = 0.942, accuracy rate = 87.4%). The metabolic pathways of cysteine and methionine metabolism, as well as arginine and proline metabolism, were significantly different between Daur and Han patients with CIS (P = 0.021 and P = 0.023, respectively).
conclusionThis exploratory study identified potential DEMs associated with CIS in populations from extremely cold rural regions and within the Daur ethnic subgroup. A preliminary ROC model constructed using these DEMs indicated their potential diagnostic value for CIS, though this requires further validation in large-scale, independent cohort studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.